A Panoptic Review on Improvement in Chemothera-peutic Properties of Cytotoxic Drugs through Calixarene

Author:

Gidwani Beena,Gupta Sanjay Kumar,Sahu Jyoti

Abstract

Cancer is one of the most fatal and complicated diseases. Chemotherapeutic drugs occupy a crucial position in cancer treatment, although it is still challenging to cure it from the root cause without harming healthy cells. Adjuvant or neoadjuvant and concurrent chemotherapies are usually used along with surgery and radiotherapy, depending on the spreading of tumour cells to its vicinity. However, it cannot wholly kill cancerous cells, which further develop after a while; the reason behind this is poor drug pharmacokinetic and biopharmaceutical parameters. Considering the approach of calixarenes, it has significantly drawn attention that can lodge drug molecules by forming inclusion complexes due to their prominent geometrical shape distinguishing them from other heterocyclic compounds. Moreover, it can be more beneficial if used with nano carrier-based systems like liposomes, liposomes, nanoparticles, micelles, milliards, and siRNA to deliver anticytotoxic agents. This review highlights the potential of calixarenes properties and nanocarrier calixarene-complexed based molecules, which provide better therapeutic properties without harming healthy cells due to their unique targeted attribution. Thus, it can overcome the problem arising from conventional therapies.

Publisher

BSP Books Private Limited

Subject

Pharmacology (medical),Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,Pharmacy

Reference72 articles.

1. K. D. Tripathi. Essentials of medical pharma-cology: jaypee brothers medical. 2018; 8th edition: 819

2. M. Yasir, M. Asif, A. Kumar, and A. Aggarval. Biopharmaceutical classification system an account. International journal of pharmtech research. 2010; 3[2]:1681–1690.

3. Vyas SP., Khar R.K. Basis of targeted drug delivery. In targeted and controlled drug delivery. C.B.S. publishers and distributors reprint 2008; 74: 42-46.

4. Stuurman FE., Nuijen B., Beijnenjh et al. Oral anticancer drugs mechanisms of low bioavailability and strategies for improvement. Clinical pharmacokinetics. 2013; 52[6]: 399-414.

5. Iqbal J., Anwar F., Afridi S. Targeted drug delivery systems and their therapeutic applications in cancer and immune pathological conditions. Infection Disorder. Drug targets. 2017; 17: 149–159.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3